Conferința Națională de Angiologie și Chirurgie Vasculară cu participare internațională Ediția 2017
|
|
- Philip Anderson
- 6 years ago
- Views:
Transcription
1 VOLUM DE REZUMATE Conferința Națională de Angiologie și Chirurgie Vasculară cu participare internațională Ediția 2017 ORGANIZATOR: Societatea Română de Angiologie și Chirurgie Vasculară Octombrie, Cluj-Napoca, România ÎN COLABORARE CU:
2 DIABETES AND OUTCOMES OF DISTAL BYPASS SURGERY IN PATIENTS WITH PHERIPHERAL ARTERIAL DISEASE Claudia Gherman 1, Andrei Eni 2, Mariana Matei 2, Alexandru Buleandră 2 1 Surgical Clincic No 2, University of Medicine and Pharmacy Iuliu Hatieganu Cluj- Napoca, 2 Vascular Surgical Clinic, County Emergency Hospital Cluj-Napoca Surgical revascularization of the lower extremity using bypass grafts to distal target arteries is an established, effective therapy for advanced ischemia. Recent multicenter data confirm the primacy of autogenous vein bypass grafting, yet there remains significant heterogeneity in the utilization, techniques, and outcomes associated with these procedures in current practice. Experienced clinical judgment, creativity, technical precision, and fastidious postoperative care are required to optimize long-term results. The patient with diabetes and a critically ischemic limb offers some specific challenges; however, numerous studies demonstrate that the outcomes of vein bypass surgery in this population are excellent and define the standard of care. Technical factors, such as conduit, and inflow/outflow artery selection play a dominant role in determining clinical success. An adequate caliber, good quality great saphenous vein (GSV) is the optimal graft for distal bypass in the leg. This study demonstrates the importance of patient selection and technical factors to outcomes, and highlights the importance of surgical judgment and operative planning in the current practice of distal bypass surgery. PERIPHERAL ARTERIAL DISEASE AND DIABETES MELLITUS THE EXPERIENCE OF VASCULAR SURGERY DEPARTAMENT, INSTITUTE OF CARDIOVASCULAR DISEASES PROF. DR. C.C. ILIESCU Sorin Liviu Băilă, Maria-Magdalena Totir, A. Parnia, P. Platon, M. Croitoru, Anca Drăgan, A. Zaharia, Șerban-Ion Bubenek-Turconi Institul de Urgență pentru Boli Cardiovasculare Prof.Dr.C.C. Iliescu București Peripheral arterial disease (PAD) is a condition characterized by atherosclerotic occlusive disease of the lower extremities. While PAD is a major risk factor for lower-extremity amputation, it is also accompanied by a high likelihood for symptomatic cardiovascular and cerebrovascular disease 1. Diabetes mellitus (DM) is a major risk factor of peripheral artery disease (PAD), leading to increased morbidity and mortality as well as an accelerated disease course. As such, a more
3 thorough understanding of the multi-factorial mechanisms underlying disease etiology for both DM and PAD is justified 2. There are 415 million people with diabetes in the world and the worldwide burden is projected to increase to 642 million people by In Romania, according PREDATOR Study, the overall age- and sex-adjusted prevalence of DM was 11.6%, of which 2.4% had unknown DM. 5 Total PAD disease prevalence based on objective testing has been evaluated in several epidemiologic studies and is in the range of 3% to 10%, increasing to 15% to 20% in persons over 70 years. 3 Although much is known regarding PAD in the general population, the assessment and management of PAD in those with diabetes is less clear and poses some special issues. At present, there are no established guidelines regarding the care of patients with both diabetes and PAD 1. This lecture will present our findings from a clinical review that was conducted in diabetic patients diagnosed with PAD, treated in Department of Vascular Surgery, Emergency Institute for Cardiovascular Disease Prof. Dr. C.C. Iliescu over a 5-year period. (January 1 st, 2012 to December 31, 2016). DIABETIC FOOT THE SIZE OF THE PROBLEM Christos Manes Internist-Diabetologist Chairman of the Greek Association for the Study of the Diabetic Foot Diseases Diabetes mellitus is a serious, chronic disease that occurs in 8.7% of the adult population worldwhite. The disease caused 1.5 million deaths in 2012 (WHO 2016).
4 Diabetes appears to dramatically increase the risk of lower extremity amputation because of infected, non-healing foot ulcers (Moxey PW. Diab Med. 2011). Rates of amputation in populations with diagnosed diabetes are typically 10 to 20 times those of nondiabetic populations and over the past decade have ranged from 1.5 to 3.5 events per 1000 persons per year. Lower limb amputation rates are 10 to 20 times higher among people with diabetes than in general population (WHO 2016). The Center of Disease Control in U.S.A estimated that the prevalence of foot ulcers in the population is 12% (CDC 2011). These lesions account for the greatest percentage of hospital admissions among diabetes patients and are the leading cause of nontraumatic lowerextremity amputations in the U.S.A. More than 60% of nontraumatic lower-limb amputations occur in people with diabetes, which amounted to nontraumatic lower-extremity amputations in 2006 (CDC-USA) Furthermore mortality following amputation was estimated to range from 13% to 40% at 1 year, 35% to 65% at 3 years, and 39% to 85% at 5 years. Peripheral neuropathy, tissue ischemia, structural foot deformities and trauma play a crucial role in the development of acute ulcerative conditions. Some common offending agents in acute infections include gram-positive cocci and gram-negative bacilli. The development of DFUs involves many etiological factors that are important to monitor in diabetes patients. Peripheral neuropathy (PN), which is present to some degree in >50% of diabetes patients aged >60 years, is one of the most important factors in the development of DFUs. Profound PN leads to loss of protective sensation and consequently to increased vulnerability to physical and thermal trauma. Foot ulcers are more likely to be of neuropathic origin, and therefore eminently preventable in developing countries. It has to be emphasized that the developing countries will experience the greatest rise in the prevalence of type 2 diabetes in the next 20 years and face the diabetic foot problem. People at greatest risk of ulceration can easily be identified by careful clinical examination of the feet. So education and frequent follow-up is indicated for these patients (AJM Boulton, Lancet 2005) When assessing the economic effects of diabetic foot disease, it is important to remember that rates of recurrence of foot ulcers are very high, being greater than 50% after 3 years. In USA examined clinical care and related costs and found that annual incremental healthcare costs ranged from $ to $ per patient with a foot ulcer, or as high as $13 billion nationally, in addition to the costs associated with diabetes itself. (Becky Mc Call Diab Care 2013) Early recognition and treatment by a multidisciplinary healthcare team are necessary for complete therapeutic resolution in patients who present with acute conditions.encouragingly several studies show a 40% to 60% reduction in rates of amputations among adults with diabetes during the past years in the United Kingdom, Sweden, Denmark, Spain, the United States of America and Australia. where multidisciplinary healthcare were organized.
5 AMPUTATIILE ÎNCOTRO? Marian Croitoru Instututul de Urgență pentru Boli Cardiovasculare Prof.Dr.C.C.Iliescu București 62 de amputatii zilnice la bolnavi cu diabet in Romania. In SUA 1 $ investit in tratamentul unui bolnav cu picior diabetic poate genera o economie pentru sistemul de sanatate de 27 pana la 51 de dolari. In urmatoarea perioada cazurile de diabet zaharat conform studiilor vor creste foarte mult. Statisticile americane constata ca ingrijirea piciorului diabetic costa mai mult decat ingrijirea bolnavilor neoplazici. Conditia bolnavilor cu ischemie critica stadiul IV este comparabila cu aceea a bolnavilor neoplazici terminali. Tratamentul endovascular este in acest moment prima optiune in rezolvarea acestor bolnavi. Noile instrumente pe care le avem la dispozitie fac ca succesul tratamentului endovascular sa mearga spre 90% si de asemenea cu procentaj foarte mare de evitare a amputatiilor. Suntem putini.. Sunt putine centre. Trebuia sa cautam a face ceva! AMPUTATIONS WHERE TO? Marian Croitoru Instututul de Urgență pentru Boli Cardiovasculare Prof.Dr.C.C.Iliescu București In Romania there are about 62 daily amputations for patients with diabetes. In USA, one dollar invested in the treatment of a patient with diabetic foot can generate an economy from 27 up to 51 dollars for the health care system. According to recent studies, In the following period the number of patients with diabetes will highly increase. American statistics reveal that diabetic foot care is comparable to the care of patients with neoplasia. The condition of patients with critical stage IV diabetic foot is very similar to patients with terminal cancers. Endovascular treatment is, at the moment, the first choice in treating these patients. New instruments make the success rate of endovascular treatment at about 90% and also help to highly decrease the number of amputations. We are few. There are very few centers. We need to do something!
6 MANAGING BELOW-THE-KNEE ARTERIAL DISEASE - ENDOVSCULAR THERAPY OF THE DIABETIC FOOT Lucian Mărginean Spitalul Clinic Județean de Urgență Târgu-Mureș Peripheral arterial disease (PAD) is a major medical concern, if left untreated it can lead to severe handicap. Longstanding diabetes affects walls of below-the-knee (BTK) arterial vessels in different degrees, and surgical therapy is sometimes limited by the patients overall condition, comorbidities and vessel caliber. Interventional radiology (IR) brings to light new approaches concerning the revascularization of these small caliber vessels, using minimally invasive techniques. The procedures do not require general anaesthesia, and the time spent in hospital decreases radically. BTK arterial disease is in our days, a major concern of IR, due to its high incidence and poor prognosis without treatment. Even partial revascularization has a great impact, since the only other options are radical, such as amputation, in some patients. Percutaneous transluminal angioplasty (PTA) of BTK lesions can improve symptoms and clinical outcomes, due to the fact that even vessels with a 1 mm caliber can be treated. The industry in continually developing devices that are designed for these small caliber vessels, giving us the possibility to treat the otherwise untreatable. Our experience is going back more than a decade, but we are continuously working to improve and address these patients as well as our esteemed colleagues, because there is an option to amputation. Keywords: below-the-knee, BTK, PTA, angioplasty. DIABETIC FOOT ULCERS PATHOPHYOLOGY, ASSESMENT AND THERAPY Centrul de Diabet și Nutriție, Cluj-Napoca Paula Pavel Foot problems in persons with diabetes remain a major public health issue and are the commonest reason for hospitalization. In diabetic patients the pathophysiology of foot disease is multifactorial including peripheral neuropathy, peripheral arterial disease, abnormal foot structure and biomechanics. Early and adequate recognition of the etiology of foot lesions is essential for accurate diagnosis and therapy management. Diabetic foot requires a multidisciplinary collaboration of health care specialists in order to address the glycemic control, infection, off-loading, vascular status and local wound care. Diabetic foot is classified into two major types: the neuropathic foot (neuropathy dominates) and the neuroischemic foot (occlusive vascular disease is the main factor, although neuropathy is present).
7 Neuropathy leads to fissures, bullae, neuropathic (Charcot) joint, neuropathic edema, and digital necrosis. Ischemia leads to pain at rest, ulceration on foot margins, digital necrosis and gangrene. Differentiating between these entities is essential because their complications are different and they require different therapeutic strategies. VASCULAR SURGERY VS. ENDOVASCULAR THERAPY IN PAD AND DIABETIC FOOT PATIENTS: WHERE DO WE STAND? Horațiu Flaviu Coman Vascular and Endovascular Surgery Clinic Martin Luther Krankenhaus, Bochum, Germany The constant development in endovascular techniques over the last years raised a fundamental question as to whether open surgery or endovascular therapy represents the optimal treatment for PAD in general and in diabetic foot patients in particular. When planning an endovascular or open surgical intervention, target vessel selection is related to the quality of the outflow vessel and its run-off. The aim of this paper is to evaluate the clinical outcomes in direct and indirect target vessel revascularization using both techniques (vascular surgery and endovascular therapy). A review of the literature data available as well as a retrospective analysis of our own experience was performed. The angiosome concept was taken into account. The endpoints evaluated were primary patency rate, limb salvage rate, complications, overall survival rate and ulcer-healing time (including adjuvant classical wound therapy alongside newest extracellular matrix wound dressing) in diabetic patients with PAD. The results show that in diabetics, according to the angiosome concept, direct endovascular revascularisation leads to significantly better wound healing and limb salvage rates compared with indirect revascularization. However in bypass surgery the artery with the best runoff should be selected as the outflow artery. In selected cases hybrid surgery, which combines both techniques, can improve the results regarding patency, limb salvage and ulcer-healing time.
8 THE MANAGEMENT OF DIABETIC FOOT CHALENGES IN ROUTINE CLINICAL PRACTICE (INTERNAL AND FAMILY MEDICINE) Sorin Crșan 5 th Medical Clinic, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, România Continuous-wave Doppler ultrasound and photoplethysmography play a key role in the early detection, severity assessment, and monitoring of peripheral arterial disease in diabetics and non-diabetics. Unfortunately, often, in routine clinical practice (internal and family medicine), these techniques are not used to their true value. The main difficulties of the diagnostic of the peripheral arterial disease and diabetic foot, discussed by the author, are the following: decreased level of awareness of diabetes-related vascular disorders among the general population, patient non adherence, minor progresses in teaching vascular medicine to medical and nursing students, reduced basic clinical skills, insufficient knowledge and understanding of current screening algorithms and of interpretation of some continuous-wave Doppler parameters (waveform shape, absolute ankle systolic pressure, and ankle-brachial index) and photopletysmographic parameters (signal aspect, absolute toe systolic pressure, and great toe and second toe-brachial index), lack of proper instrumentation, lack of reimbursement of some of time-consuming techniques, real exam costs, sometimes unreliable values in patients with medial arterial calcification. Keywords: continuous-wave Doppler ultrasound, photoplethysmography, ankle-brachial index, peripheral arterial disease, diabetic foot REVASCULARIZATION BELOW-THE-KNEE: WHAT CAN WE DO MORE FOR LIMB SALVAGE? Kiriaki Kalligianni Vascular Surgeon,,,Hygeia Hospital Athens Greece The anatomic common denominator of Diabetes and CLI is the presence of severe below-theknee arterial occlusive lesions.our purpose is to summarize new developments in revascularization and advanced surgical and endovascular techniques to treat BTK lesions especially in diabetic patients with the primary goal the re-establishment of pulsatile, straightline flow to the foot. Although the bypass procedures remain the gold standard, endovascular techniques are the new standard of care being today the first-line approach in the majority of patients presenting with CLI. Extended distal below-the-ankle bypasses, tibial endovascular interventions with antegrade or retrograde pedal access, pedal-plantar loop technique or transcollateral recanalization, angiosome directed approach and novel devices such drug coated balloons and drug eluting stents are a key part of our surgical armamentarium to achieve a complete revascularization. Increasing technical success rates, low frequency of
9 complications, high limb salvage rates of about 90% and amputation free survival rates even in diabetic patients with long segment and diffuse disease justify the use of advanced surgical and mainly endovascular therapy focused in this anatomic area. BTK NO LIMIT! Mihai Crețeanu Jr. Laboratorul de Radiologie și Imagistică Medicală Spitalul Clinic Județean de Urgență Sf.Ioan Cel Nou, Suceava, România Tehnicile minim invazive au fost introduse in cadrul Spitalului Judetean de Urgenta Sf. Ioancel Nou Suceava din anul Dintre procedurile endovasculare cele mai frecvent intalnite s-au dezvoltat cele de angioplastie cu balon, angioplastie cu stent in situatiile de ischemie critica in special la pacientii cu diabet. Numarul de interventii a crescut de la an la an , , , , iar daca initial leziunile tratate predominant (>60%) erau deasupra genunchiului, acum s-a produs o schimbare in sensulca (>75%) dintre leziuni sunt sub genunchi. Rata de success a interventiilor este de peste 95%, iar rata de complicatii sub 3%. Abordarea in echipa multidisciplinara a piciorului persoanei cu diabet(diabetolog, neurolog, chirurg vascular, chirurg generalist, ortoped, podiatru, asistent educator) a permis reducerea cu pana la 50% a numarului de amputatii majore. The minimally invasive techniques have been introduced at the Suceava County Hospital St. Ioan cel Nou since Most of these endovascular procedures were balloon or stent angioplasties in critical ischemia especially for patients with diabetes mellitus. The number of interventions increased from year to year , , , , and if the injuries originally treated (> 60%) were above the knee (ATK), there was a change in this sense : (> 75%) of the injuries are below the knee (BTK). The success rate of the interventions is over 95% and the complication rate below 3%. The multidisciplinary team (diabetologist, vascular surgeon, orthopedic surgeon, neurologist, podiatrist, interventionist radiologist and educational support nurse) who approaches diabetic foot of the person with diabetes have led to reduction of major amputations by up to 50%.
10 FOOT SCREENING VITAL TO DIABETIC HEALTH Cynthia Formosa State Registered Podiatrist from the Department of Health, Malta The impact of diabetes-related complications and amputations on individuals, families and the society is huge. The impact on the quality of life for the individual is massive. Every 20 seconds someone in the world loses a limb to diabetes. However 4 out of 5 amputees could be prevented, given prompt and proper foot care attention, correct advice and rapid access to preventive services and screening. Every person with diabetes should receive annual checkups and foot screening in order to identify foot pathologies and deformities which places the foot at risk of ulceration and amputations. A paradigm shift on how to screen for risk factors in the high risk foot using high quality evidence is urgently required if the risk of foot ulceration and its devastating consequences are to be improved. This paper highlights how the role of the podiatrist as part of a multi-disciplinary team can help save limbs! It presents the findings of studies conducted to compare the accuracy of different physiological tests used by various health care professionals for the identification of lower limb diabetic related pathologies. MEDICAL INFRARED THERMOGRAPHY ITS USE AND FUTURE APPLICATION AS A CLINICAL TOOL Manager of Podiatry Services in Malta Alfred Gatt Thermography, the medical infrared imaging of the human body, is an emergent technology that holds a lot of potential as a possible tool for the examination of the feet of patients living with diabetes, amongst other diseases, since temperature can be an indicator of tissue perfusion. The emissivity of heat, or lack of it, from the body may be an indicator of disease processes, since infection, inflammation and decreased perfusion may alter the normal thermal pattern of the hands and feet. The basic principles of thermography together with its application to obtain normative thermographic patterns of the hands and feet, together with its application in the assessment of the diabetic foot and rheumatoid arthritis will be discussed. Furthermore, recent research in the field of peripheral arterial disease will be explored to demonstrate the possibilities of this exciting new field for medical diagnosis. The purpose of the presented study was to investigate whether heat emitted from the hands and feet of patients with diabetes (DM) and peripheral arterial disease (PAD) differed significantly from those without PAD. Out of 223 randomly selected participants (430 limbs) who were initially tested, 62 limbs were categorized as DM+PAD and 22 limbs as DM without PAD. Subjects
11 with evidence of peripheral neuropathy were excluded. Participants underwent thermographic imaging. Automatic segmentation of Regions of Interest extracted the temperature data. Results show a significant difference in temperature in all the toes between the two groups (p=0.005, p=0.033, p=0.015, p=0.038 and p=0.02 for toes 1-5 respectively). A Palmar/Plantar Thermographic Index composed of the mean Maximum Palm Temp/mean Minimum Forefoot Temp revealed significant difference between the two groups (p=.016). The mean forefoot temperature in DM+PAD was significantly higher than that in DM (p=.019), with DM+PAD having a higher mean temperature (28.3 o C) compared to DM (26.2 o C). Similarly, the toes of subjects with DM+PAD were significantly warmer than those of subjects with PAD alone. Contrary to expectations the mean toe and forefoot temperatures in DM patients with PAD is higher than in those without PAD. This unexpected result could be attributed to disruption of noradrenergic vasoconstrictor thermoregulatory mechanisms with resulting increased flow through cutaneous vessels and subsequent increased heat emissivity. Results from the presented studies demonstrate that thermography may have potential in detecting temperature differences associated with both PAD and synovitis. TERAPIA CHIRURGICALĂ PENTRU ANEVRISMUL ARTEREI POPLITEALE Spitalul Militar Central, București I.Droc, M.Dumitrașcu, L.Stan Anevrismul arterial popliteal (PAA) este relativ rar întâlnit într-un procent estimat de 0,1-1% din populație. Acestea reprezintă cea mai comună formă de anevrisme periferice, sunt adesea bilaterale și uneori sunt concomitent cu anevrismele abdominale sau femurale. Ele adesea sunt gresit diagnosticate și primar conferă un risc de ischemie a membrelor și pierderea membrelor. Anevrismul arterial popliteal se soldeaza mai frecvent cu pierderea membrului inferior decat a vietii. Imagistica este în primul rând realizata cu ultrasunete duplex și cu angiografia CT. Numai în câteva cazuri efectuăm angiografie pentru planificarea operativă. Reparația este recomandată pentru PAA> 2 cm diametru la pacienții cu risc crescut. Tehnica chirurgicală pentru a exclude anevrismul este legarea proximală și distală a PAA cu o revascularizare a segmentului scurt (proximal cu by-pass-ul arterial popliteal, distal folosind grefa autologă a venei sau o grefă protetică). Reparația chirurgicală deschisă este testată în timp, sigură și durabilă la pacienții selectați în mod corespunzător. Tratamentul endovascular este promițător, dar este nevoie de date pe o lungă durată.
12 SURGICAL THERAPY FOR POPLITEAL ARTERY ANEURYSM Central Military Hospital, Bucharest I.Droc, M.Dumitrașcu, L.Stan Popliteal arterial aneurysm (PAA) are relatively rare occurring in an estimated 0.1-1% of the population. They represent the most common form of peripheral aneurysms, are often bilateral and are sometimes concomitant with abdominal or femoral aneurysms. They are under diagnosed and primary confer o risk for limb ischemia and limb loss. Popliteeal arterial aneurysm are more often limb threatening than life threatening. Imaging is primarily with duplex ultrasonography and than CT angiography. Only in few cases we perform angiography for operative planning. Repair is recommended for PAA> 2cm in diameter in good risk patients. The surgical technique to exclude the aneurysm is proximal and distal ligation of the PAA with a short segment revascularization (proximal to distal popliteal artery by-pass using autologous vein graft or a prosthetic graft). Open surgical repair is time tested, safe and durable in properly selected patients. the endovascular treatment is promising but long term patency data is needed. THERMAL ABLATION OF POPLITEAL FOSSA PERFORATORS 1.Clinica Vascul Art Cluj, Romania, 2.Eskulap Hospital, Bydgoszcz, Poland R.Milleretˡ, M..Molski², I.Droc³ 3.Central Military Hospital -Bucharest, Romania Steam is the latest of the thermal endovenous techniques to enter clinical use. It was introduced in 2008 as a cheaper but as effective alternative to laser and radio-frequency. The principle is to inject in the vein pulses of water vapors at 120 C, each pulse delivering 60 joules of energy in the lumen. Steam is injected under pressure: the first pulse dislodges the blood, the next ones heat the vein wall. A stainless steel catheter of 5F gauge is used, it is flexible enough to navigate through tortuosities without using a guide wire. Two lateral holes close to the tip eject the steam, avoiding the risk of heating deep veins when heating the junctions. A comparative animal study by S.Thomis and all (1) showed that immediate shrinking was more pronounced with steam than with Closure Fast radio frequency catheter and 1470 nm TULIP fiber laser. Perivenous damage was less seen, although the number of cases was not sufficient to obtain statistical significance.
13 R.Milleret (2) published the results of a multi center study performed in France. Obliteration rate at 6 months was 96 %. A multicenter study of tributary ablation showed, with less pigmentation and inflammatory reactions than after foam sclerotherapy with 97% closure rate at 6 months. A second generation device allows elective ablation of tributaries and reticular veins (Miravas ) In conclusion, steam ablation is a safe alternative to other thermal techniques, it can be applied to tortuous or superficial veins which could not be treated by laser of radio frequency. BOALA VENOASĂ CRONICĂ, ASPECTE PROFILACTICE Daniela Radu Clinica 1 Chirurgie, Universitatea de Medicină și Farmacie V.Babeș, Timișoara Introducere Screening-urile populationale realizate prin studii epidemiologice nationale si internationale (SEPIA, PEGAS, VEIN CONSULT) au identificat persoane cu risc crescut de a dezvolta IVC. In profilaxia acestei afectiuni sunt implicati multi factori etiologici; in acest studiu am luat in considerare doar 2 cauze importante cu risc crescut de IVC si anume: factorul genetic si pozitia favorizanta. Factorul genetic, mostenirea familiala este identificata intre 64,8% pe linie maternal si 13,9% pe linie paterna in studiul Vein Consult. Al doilea factor de risc major in aparitia bolii este ortostatismul prelungit, precum si pozitia sezanda indelungata. Acestea, intr-o perioada variabila de timp pot determina aparitia ectaziilor venoase si a insuficientei venoase cronice. Practic putem afirma ca toata populatia care are acesti factori de risc are un grad de IVC, fapt demonstrat de edemele declive, cu accentuare vesperala. Scop: identificarea si eliminarea factorilor predominanti implicati in etiologia BVC. Metoda: Studiu retrospectiv, 5 ani ( ) pe pacienti dispensarizati in Cabinetul de Flebologie al SCJUPBT. Dispensarizarea generala a pacienţilor se face în grupuri distincte: persoane sănătoase, dar cu vulnerabilităţi prin vârstă, stări fiziologice speciale, persoane sănătoase cu factori de risc ereditari, pacienţi cu boli cronice sau în convalescenţă după imobilizare prelungită la pat. Am identificat 2 loturi de pacienti: primul lot: pacienti cu istoric familial de BVC si al 2 lea lot, format din pacienti care urmeaza sa fie supusi unei interventii cu risc tromboembolic crescut, neoplazici, traumatisme ale membrelor inferioare, trombofilia sau diferite afectiuni care cresc vascozitatea sanguina sau stari fiziologice cu risc trombotic (sarcina) calatoria cu avionul (tromboza calatorului). Profilaxia este diferentiata ca durata si metode. Pentru primul lot stabilirea planului de control periodic se realizează în funcţie de: stadiul afecţiunii, necesitatea ajustării tratamentului, complianţa şi respectarea indicaţiilor de către pacienţi. Periodic are loc evaluarea eficienţei monitorizării pacienţilor cu încadrarea întro categorie suplimentară a pacienţilor necomplianţi sau care nu pot respecta indicaţiile medicale din alte motive. In situatia in care, cu toata profilaxia corect aplicata, afectiunea progreseaza, se intervine cu tratament curativ conform ghidurilor si protocoalelor de terapie in functie de stadiul afectiunii. Rezultate: 72% nu au respectat/ au respectat partial indicatiile
14 medicului dupa momentul diagnosticarii/ tratamentului chirurgical; 34% au revenit cu IVC avansata/complicatii. In concluzie, atragem atentia asupra preventiei acestei boli care chiar daca la debut nu prezinta o simptomatologie alarmanta pentru pacient, pe viitor va necesita o terapie curativa cu costuri crescute, fiind o boala cronica evolutiva, grevata de scaderea calitatii vietii. Recomandam, in afara educatiei sanitare corecte, terapie adecvata, concordanta cu stadiul Insuficientei venoase cronice. Cu toate progresele realizate in diagnosticul si terapia acestei afectiuni, evolutia bolii depinde mult de modul in care pacientul constientizeaza existenta si gravitatea afectiunii. Profilaxia IVC si a complicatiilor este esentiala la pacientii cu risc, ea trebuie aplicata corect si complet pe toata durata riscului, la unii pacienti toata viata. Complianta pacientului depinde in mare masura de increderea in medic si este determinanta in stoparea progresiei sau aparitiei afectiunii. Recomandam, in afara educatiei sanitare corecte, terapie adecvata, concordanta cu stadiul Insuficientei venoase cronice. CHRONIC VENOUS DISEASE, PROFILATIC ASPECTS Daniela Radu Clinic 1 Surgery, University of Medicine and Pharmacy "V.Babes", Timisoara Introduction Population Screening Through National and International Epidemiological Studies (SEPIA, PEGAS, VEIN CONSULT) identified people at high risk of developing IVC. Many etiological factors are involved in the prophylaxis of this condition; in this study, we considered only 2 important causes at high risk of CVD, namely: genetic factor and favorable position. The genetic factor, family inheritance is identified between 64.8% maternal and 13.9% paternal in the Vein Consult study. The second major risk factor in the onset of the disease is prolonged orthostatism, as well as long standing position. These, over a variable period of time, can cause venous ectasis and chronic venous insufficiency. Basically, we can say that all the population with these risk factors has a IVC degree, as evidenced by declivous edema, with a vesperal accentuation. Purpose: identification and elimination of predominant factors involved in the etiology of BVC. Method: Retrospective study, 5 years ( ) on dispensarized patients in SCJUPBT's Flebology Cabinet. General patient dispensing is done in distinct groups: healthy individuals but with age-related vulnerabilities, special physiological states, healthy individuals with hereditary risk factors, chronic illnesses, or convalescence after prolonged bed rest. We identified 2 batches of patients: the first batch: patients with a family history of BVC and a second batch of patients who are to undergo surgery with increased thromboembolic risk, neoplasms, lower limb trauma, thrombophilia or various diseases that increase blood viscosity or physiological states with thrombotic (pregnancy) air travel (thrombosis of the traveler). Prophylaxis is differentiated as duration and methods. For the first batch, the establishment of the periodic control plan is based on: the stage of the disease, the need to adjust the treatment, the compliance and the observance of the indications by the patients. Periodic assessment of the effectiveness of patient monitoring is carried out by fitting an additional category of non-compliant patients or failing to comply with medical indications for other reasons. If all the prophylaxis applied, the disease progresses, it is treated with curative treatment according to the guidelines and the protocols of the therapy depending on the stage of the disease. Results: 72% did not partially follow the doctor's instructions after diagnosis / surgical treatment; 34% returned with advanced IVC / complications.
15 In conclusion, we draw attention to the prevention of this disease, which even if onset does not present an alarming symptom for the patient, in the future will require a curative therapy with increased costs, being a chronic evolutionary disease, strike by the decrease in quality of life. We recommend, besides proper health education, appropriate therapy, consistent with the chronic venous insufficiency. With all the advances made in the diagnosis and therapy of this condition, the evolution of the illness depends largely on how the patient is aware of the existence and severity of the disorder. IVC prophylaxis and complications is essential in patients at risk, it should be applied correctly and completely throughout the risk in some patients throughout life. Patient compliance largely depends on physician confidence and is determinant in stopping the progression or occurrence of the disorder. We recommend, besides proper health education, appropriate therapy, consistent with the chronic venous insufficiency. TRATAMENTUL INSUFICIENȚEI VENOASE CRONICE CU LASER ENDOVENOS I.Cazan, G. Băroi, C. Strobescu-Ciobanu, R.F.Popa Clinica de Chirurgie Vasculară, Spitalul Clinic Județean de Urgență Sf.Spiridon Iași, România In Romania, boala varicoasa are o incidenta intre 30 si 50% la populatia adulta, de regula, cu varsta cuprinsa intre 30 si 40 de ani. Tot in acest context, trebuie subliniat faptul ca femeile sunt mai afectate, raportul de incidenta pe sexe fiind de 3/2 (femei barbati). Terapia LASER endovenoasă (EVLO) îndeplineşte cele mai multe dintre dezideratele unui tratament modern al insuficientei venoase fiind: eficientă - rată de succes a EVLO de 94% la 3 ani (cea mai mare dintre terapiile endovenoase), minim invazivă, complicaţii rare (rata TVP similară tehnicii chirurgicale clasice, darcu rată de complicaţii locale mult diminuată). In aceasta lucrare vom prezenta experienta clinicii pe parcursul a 5 ani intre insumand un numar de 154 de interventii EVLO. Consecutiv acestei proceduri pentru completarea tratamentului s-au efectuat flebectomii etajate sau ca opţiune de elecţie scleroterapia ecoghidată. Pacientii au fost urmariti echografic la o saptamana si la o luna postoperator, la toate intervalele de control s-a constatat persistenta inchiderii VSI. Cuvinte cheie : terapie laser endovenoasa, vena safena interna, sclerozare echoghidata. CHRONIC VARICOSE DISEASE TREATMENT WITH ENDOVENOUS LASER I.Cazan, G. Băroi, C. Strobescu-Ciobanu, R.F.Popa Vascular Surgery Clinic,Clinical County Hospital Sf.Spiridon Iași, România In Romania, varicose disease has an incidence between 30 and 50% in the adult population, with ages ranging from 30 to 40 years. In this context, we need to underline the fact that
16 women are more affected, the ratio being 3/2 women to men. Endovenous laser therapy (EVLO) fulfills most of the requirements of a modern treatment for venous insufficiency: efficiency success rate of 94% at 3 years (the greatest among endovenous treatment), minimally invasive, and rare complications (DVP occurrence rate similar to the classical surgical approach but with a much diminished local complications rate). In this paper we will present our clinic s experience in the course of 5 years (between 2011 and 2016) showcasing a number of 154 EVLO interventions. Subsequently to this procedure, for treatment completion, sequential phlebotomies have been performed or, optionally, echoguided elective sclerotherapy. Pacients were followed echographically at one week and one month postoperatively, and at all these control intervals persistent ISV closure was observed. Key words: endovenous laser therapy, internal saphenous vein, echoguided sclerotherapy ACTUALITĂȚI ÎN TRATAMENTUL TROMBOZEI VENOASE PROFUNDE. TRATAMENTUL TROMBOZEI VENOASE PROFUNDE ÎN CLINICA I CHIRURGIE A SPITALULUI CLINIC JUDEȚEAN DE URGENȚĂ TIMIȘOARA O STATISTICĂ PE 5 ANI MS. Murariu 1, Loredana Stroescu 2, Mihaela Avram 1, N. Pop 2, B. Magiar 2, A. Parau 2, Oana Radu 2, S. Pop 1, C. Ivan 1, Daniela Radu 1, V. Ivan 2, S. Olariu 1 1_ Clinica I Chirurgie, Departamentul X Chirurgie, Universitatea de Medicină și Farmacie Victor Babeș Timișoara, România 2 Spitalul Clinic Județean de Urgență Pius Brînzeu Timișoara, România Introducere. Tromboza venoasă profundă (TVP) şi embolia pulmonară (EP) sunt forme clinice ale tromboembolismului venos (TEV). O dată cu apariția unor noi anticoagulante, putem completa tratamentul tromboembolismului venos. Material și metodă. Am studiat opțiunile de tratament anticoagulant pentru TEV care includ heparina, heparine cu greutate moleculară redusă, antagoniști de vitamina K și utilitatea unor noi anticoagulante conform recomandărilor ghidurilor internaționale. De asemenea, am studiat cazurile cu tromboză venoasă profundă (TVP) a pacienților internați în Clinica I Chirurgie a Spitalului Clinic Județean de Urgență Timișoara în perioada Ne-am orientat pe diagnosticul și tratamentul tromboembolismului venos (TEV). Rezultate. În statistica noastră de tratament al trombozei venoase profundă (TVP) nu am avut mortalitate la pacienții internați cu TVP. Concluzii. Tratamentul tradițional al TVP este eficient, dar o adaptare la folosirea noilor medicamente anticoagulante poate fi utilă pentru pacienți datorită faptului că prezintă unele avantaje. De asemenea, unele metode mecano-chimice nu trebuie să ne descurajeze în a le pune în practică dacă avem posibilitatea.
17 CURRENT TREATMENT OF DEEP VEIN THROMBOSIS. TREATMENT OF DEEP VEIN THROMBOSIS IN THE FIRST SURGICAL CLINIC OF THE EMERGENCY COUNTY HOSPITAL PIUS BRÎNZEU TIMISOARA - 5 YEARS STATISTICS MS. Murariu 1, Loredana Stroescu 2, Mihaela Avram 1, N. Pop 2, B. Magiar 2, A. Parau 2, Oana Radu 2, S. Pop 1, C. Ivan 1, Daniela Radu 1, V. Ivan 2, S. Olariu 1 1 First Clinic of Surgery, Department X of Surgery, University of Medicine and Pharmacy Victor Babeș Timișoara, România 2 Emergency County Hospital Pius Brînzeu Timișoara, România Introduction. Deep vein thrombosis (DVT) and pulmonary embolism (PE) are clinical forms of venous thromboembolism (VTE). As new anticoagulants appear, we may complete the therapeutic treatment of VTE. Material and method. We studied the anticoagulation options for acute VTE which include unfractionated heparin, low molecular weight heparin, the vitamin K antagonists (VKAs) and the utility of the new antithrombotic drugs as recommended by the international Guidelines. Also, we studied the cases with deep vein thrombosis (DVT) of the hospitalized patients in the First Surgical Clinic of the Emergency County Hospital Timisoara Pius Brînzeu Timișoara in the period between We focused on the diagnosis and treatment of venous thromboembolism (VTE). Results. In our 5 years statistic of treatment of DVT we have no mortality at the hospitalized patients with DVT. Conclusions. The traditional treatment of DVT is effective, but an adjustment for using the new antithrombotic drugs may be useful to the patients because they have some advantages. Also, some mechanical-chemical methods must not discourage us from putting them into practice if we have the possibility. GHIDURILE DE PROFILAXIE A TROMBOZEI VENOASE PROFUNDE ÎN CHIRURGIA CLASICĂ SUNT VALABLE ÎN CHIRURGIA MODERNĂ? Avram M.F. 1, Cădariu Fl. 1, Avram I.O. 2,Koukoulas D. 3, Murariu M. 1,Olariu S 1 1 Clinica 1 Chirurgie, UMF V.Babeș, Timișoara, România 2 CaritasKlinikum Saarbrücken, Germania 3 Spitalul Municipal Lugoj, România Introducere: Fără efectuarea profilaxie riscul de tromboză venoasă profundă (TVP) și tromboembolism pulmonar (TEP) este de 10% în intervențile de chirurgie generală, de 30% în chirurgia ginecologică și ajunge la 50% în chirurgia ortopedică și chirurgia oncologică
18 majoră. În prezent chirurgia laparoscopică a câștigat teren în fața procedurilor chirurgicale clasice, deschise. Material şi metodă:. Am analizat beneficiile profilaxiei TVP în chirurgia laparoscopică.am analizat 648 de pacienți operați laparoscopic în Clinica Chirurgie 1. În timpul intervențiilor laparoscopice am identificat ca fiind factori de risc specifici pentru TVP: poziția pacientului și presiunea crescută indusă de pneumoperitoneu. Anticoagularea postoperatorie a fost introdusă la toți pacienții a căror operație a durat peste 2 ore și nu au avut risc de sângerare considerabil. Toți pacienții au fost examinați clinic postoperator, căutându-se semne locale de TVP și a fost efectuat doppler vascular în cazul paciențiilor a căror intervenție a fost mai lungă de 2 ore. Rezultate: Au fost confirmate eco-doppler 4 cazuri de TVP, dar nici unul din acești pacienți nu a avut acuze subiective sau semne clinice de tromboză. Luăm în discuție și ghidurile și recomandările de profilaxie a TVP și TEP elaborate de American College of Chest Physicians și de The Society of American Gastrointestinal and Endoscopic Surgeons subliniind aspectele legate de chirurgia endoscopică. Concluzii: Riscul relativ de TVP și TEP în chirurgia laparoscopică față de cea clasică nu este bine definit.studii extinse, bine conduse sunt necesare pentru elaborarea unor ghiduri specifice intervențiilor laparoscopice. ARE THE GUIDELINES FOR DEEP VEIN THROMBOSIS PROFILAXY IN CLASICAL SURGERY SUITABLE FOR MODERN SURGERY? Avram M.F. 1, Cădariu Fl. 1, Avram I.O. 2,Koukoulas D. 3, Murariu M. 1,Olariu S 1 1 Surgery Clinic no. 1, UMF V.Babeș, Timișoara, România 2 CaritasKlinikum Saarbrücken, Germany 3 Lugo Hospitalj, România Introduction: When no prophylaxis is made, the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) is 10% after general surgery interventions, 30% in gynecologic surgery and 50% in orthopedic surgery and major interventions for malignancies. Nowadays surgical procedures are mainly laparoscopic, open surgeries becoming less frequent than in the past. Material and method: We analyze and discuss the benefit of DVT prophylaxis in laparoscopic procedures. We included in the study 648 patients that underwent laparoscopic surgery. During the operation the position and the high intraabdominal pressure are risk factors for DVT. Therefore we introduced postoperative anticoagulation to all cases that lasted more than 2 hours and had no important hemorrhagic risk. We clinically checked all the patients for signs of DVT, we performed vascular echo Doppler examination to all patients with surgery that lasted longer than 2 hours.
19 Results: In 4 patients the diagnosis of DVT was confirmed, although no clinical signs or symptoms were present. We also discuss the current DVT prophylaxis guidelines elaborated by the American College of Chest Physicians as well as the recommendations elaborated by The Society of American Gastrointestinal and Endoscopic Surgeons highlighting the aspects regarding endoscopic surgery. Conclusions: The relative risk of DVT in laparoscopic surgery versus open procedures is not well defined. Laparoscopic intervention specific guidelines based on large, well conducted studies are needed. CHIRURGIA DE ZI FLEBOLOGICĂ EVOLUŢIE ŞI MANAGEMENT Cădariu Florentinaˡ, Enache Alexandra², Avram Mihaelaˡ, Olariu Sorinˡ 1 UMFT, Clinica Chirurgie 1, Timişoara, România 2 UMFT, Institutul de Medicină Legală, Timişoara, România Introducere: Lucrarea prezintă, pornind de la experiența personală, posibilităţile de management ale bolii varicoase în sistemul chirurgiei de zi și beneficiile economice aduse de aceasta Material şi metodă: Din totalul consultaţiilor chirurgicale acordate pacienţilor în Cabinetului Medical Chirurgie şi Flebologie Dr. Cădariu Florentina consultaţiile flebologice au reprezentat 14,7% din activitate. Având în vedere existenţa relativ recentă a flebologiei şi a chirurgiei ambulatorii, majoritatea cazurilor nou înregistrate prezintă insuficienţă venoasă cronică în stadii avansate IV-VI, cu leziuni trofice. Rezultate: Situaţia pacienţilor dispensarizati la nivelul cabinetulul se prezintă astfel: Etiologic: Varice hidrostatice 93,6%, Sindrom posttrombotic 6,4%; Evolutiv: IVC Clasa I-II 25%, IVC Clasa III-IV 57,5%, IVC Clasa V-VI 17,5%. Tratamentul complex al bolii varicoase este individualizat, costul total al acestuia crescând proportional cu stadiul evolutiv al bolii, fiind de până de zece ori mai mare decât costul profilaxiei primare. Concluzii:Activitatea în sistemul chirurgiei de zi necesită introducerea unor protocoale de selecţie a pacienţilor, protocoale şi ghiduri terapeutice, protocoale de colaborare cu MF, spital. În elaborarea acestor documente este necesară colaborarea între specialişti, asociaţiile profesionale şi instituţiile naţionale chirurgic, anestezişti, Colegiul Medicilor, Ministerul Sănătăţii, CNAS.
20 PHLEBOLOGICAL DAY SURGERY - EVOLUTION AND MANAGEMENT Cădariu Florentinaˡ, Enache Alexandra², Avram Mihaelaˡ, Olariu Sorinˡ 1 UMFT, Clinica Chirurgie 1, Timişoara, România 2 UMFT, Institutul de Medicină Legală, Timişoara, România Introduction: The paper presents, based on personal experience, the possibilities of management of varicose disease in the day surgery system and the economic benefits brought by it. Material and method: Of the total surgical consultations given to patients in "Cabinet Medical Surgery and Flebology Dr. Cădariu Florentina" phlebological consultations accounted for 14.7% of the activity. Given the relatively recent existence of phlebology and ambulatory surgery, most newly recorded cases have chronic venous insufficiency in advanced IV-VI stages with trophic lesions. Results: The situation of dispensary patients at the cabinet level is as follows: Etiologic: Hydrostatic varicose veins 93.6%, post-thrombotic syndrome 6.4%; Evolution: IVC Class I-II 25%, IVC Class III-IV 57.5%, IVC Class V-VI 17.5%. Complex treatment of varicose disease is individualized, with its total cost increasing proportionally to the evolutionary stage of the disease, up to ten times higher than the cost of primary prophylaxis. Conclusions: Activity in the day surgery system requires the introduction of patient selection protocols, protocols and therapeutic guides, collaboration protocols with the family doctors, hospital. The elaboration of these documents requires good collaboration between the specialists, the professional associations and the national institutions - surgical, anesthetists, the College of Physicians, the Ministry of Health, the CNAS. ACTUALITĂȚI ÎN TRATAMENTUL ANTITROMBOTIC AL ARTERIOPATIEI CRONICE OBLITERANTE Olinic D., Tătaru D., Homorodean C., Spînu M., Olinic Maria Secţia de Cardiologie II (Cardiologie Intervenţională), Spitalul Clinic Judeţean de Urgenţă Cluj, Universitatea de Medicină şi Farmacie Iuliu Haţieganu Cluj-Napoca Această lucrare acoperă actualitățile în tratamentul antitrombotic pentru arteriopatia cronică obliterantă a membrelor inferioare (ACOMI). Terapia dublă antiplachetară cu ticagrelor (60 mg b.i.d) și aspirină ( mg zilnic) asigură o reducere semnificativă a evenimentelor
21 adverse cardiovasculare majore și poate fi luată în considerare la pacienții cu ACOMI simptomatică și cu antecedente de infarct miocardic. Utilizarea unui nou antagonist al receptorului de trombină, denumit vorapaxar, în asociere cu aspirină și / sau clopidogrel, reduce riscul de ischemie acută și de revascularizare periferică la pacienții cu ACOMI simptomatică, dar cu costul unui risc crescut de sângerare. Rivaroxaban (2,5 mg b.i.d) plus aspirină (100 mg pe zi) este prima asociere antitrombotică care a demonstrat un beneficiu semnificativ pentru pacienții cu ACOMI, în ceea ce privește obiective importante: mortalitatea totală și mortalitatea cardiovasculară. Prin urmare, această asociere are cele mai puternice dovezi pentru prevenție secundară. UPDATES IN ANTITHROMBOTIC TREATMENT IN PERIPHERAL ARTERY DISEASE Olinic D., Tătaru D., Homorodean C., Spînu M., Olinic Maria Interventional Cardiology, County Emergency Hospital Cluj, University of Medicine and Pharmacy Cluj-Napoca, România This review covers updates in antithrombotic use for peripheral arterial disease (PAD). Dual antiplatelet therapy with ticagrelor (60 mg b.i.d) and aspirin ( mg daily) provides a significant reduction in major adverse cardiovascular events and may be considered in symptomatic PAD patients with prior myocardial infarction. The use of a new thrombin receptor antagonist, vorapaxar, on top of aspirin and/or clopidogrel, reduces the risk of acute limb ischemia and peripheral artery revascularization in patients with symptomatic PAD, at the cost of an increased risk for bleeding. Rivaroxaban (2.5 mg b.i.d) plus aspirin (100 mg daily) is the first antithrombotic association that proved significant benefit for PAD patients, in terms of strong endpoints: total mortality and cardiovascular mortality. Therefore, this association has the strongest evidence for secondary prevention. TRATAMENTUL ENDOVSCULAR AL ANEVRISMULUI DE AORTĂ TORACICĂ - PREZENTARE DE CAZ Spitalul Militar Central, București I. Droc,.l.Vlad,,L.Stan Pacient in varsta de 45 de ani, hipertensiv, dislipidemic, consumator cronic de alcool, internat pe sectia noastra in urma cu 5 luni cu anevrism de aorta toracica post-traumatic (dupa un
Surgical Options for revascularisation P E T E R S U B R A M A N I A M
Surgical Options for revascularisation P E T E R S U B R A M A N I A M The goal Treat pain Heal ulcer Preserve limb Preserve life The options Conservative Endovascular Surgical bypass Primary amputation
More informationCurrent Status of Endovascular Therapies for Critical Limb Ischemia
Current Status of Endovascular Therapies for Critical Limb Ischemia Bulent Arslan, MD Associate Professor of Radiology Director, Vascular & Interventional Radiology Rush University Medical Center bulent_arslan@rush.edu
More informationPATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE
PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE Disclosure Speaker name: DR. Manar Trab I have the following potential
More informationCritical Limb Ischemia A Collaborative Approach to Patient Care. Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017
Critical Limb Ischemia A Collaborative Approach to Patient Care Christopher LeSar, MD Vascular Institute of Chattanooga July 28, 2017 Surgeons idea Surgeons idea represents the final stage of peripheral
More informationVASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS
VASCULAR DISEASE: THREE THINGS YOU SHOULD KNOW JAMES A.M. SMITH, D.O. KANSAS VASCULAR MEDICINE, P.A. WICHITA, KANSAS KANSAS ASSOCIATION OF OSTEOPATHIC MEDICINE ANNUAL CME CONVENTION APRIL 13, 2018 THREE
More informationElectroencephalography (EEG) alteration in Autism Spectum Disorder (ASD)
Electroencephalography (EEG) alteration in Autism Spectum Disorder (ASD) FLORINA RAD 1, CAMELIA CIOBANU 2, GIANINA ANGHEL 3, IULIANA DOBRESCU 4 ABSTRACT There is a controversial relationship between Autism
More informationPUT YOUR BEST FOOT FORWARD
PUT YOUR BEST FOOT FORWARD Bala Ramanan, MBBS 1 st year vascular surgery fellow Introduction The epidemic of diabetes and ageing of our population ensures critical limb ischemia will continue to grow.
More informationAsociatia pentru Servicii Mobile de Ingrijire Paliativa in 2010
de Ingrijire Paliativa in 2010 Echipa SMIP Dr. Oana Donea, medic primar oncolog cu supraspecializare in ingrijire paliativa Luciana Negulescu, asistent medical principal Alina Lazar, asistent social Activitatile
More informationTHE EFFICIENCY OF LOW MOLECULAR WIGHT HEPARINS IN THE PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN GENERAL SURGERY
FARMACIA, 2012, Vol. 60, 1 127 THE EFFICIENCY OF LOW MOLECULAR WIGHT HEPARINS IN THE PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN GENERAL SURGERY ANDREEA NICOLETA SAFTA 1, VLAD DENIS CONSTANTIN
More informationMabel Labrada, MD Miami VA Medical Center
Mabel Labrada, MD Miami VA Medical Center *1-Treatment for acute DVT with underlying malignancy is for 3 months. *2-Treatment of provoked acute proximal DVT can be stopped after 3months of treatment and
More informationJohn E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division
John E. Campbell, MD Assistant Professor of Surgery and Medicine Department of Vascular Surgery West Virginia University, Charleston Division John Campbell, MD For the 12 months preceding this CME activity,
More informationImaging Strategy For Claudication
Who are the Debators? Imaging Strategy For Claudication Duplex Ultrasound Alone is Adequate to Select Patients for Endovascular Intervention - Pro: Dennis Bandyk MD No Disclosures PRO - Vascular Surgeon
More informationChronic Venous Insufficiency Compression and Beyond
Disclosure of Conflict of Interest Chronic Venous Insufficiency Compression and Beyond Shawn Amyot, MD, CCFP Fellow of the Canadian Society of Phlebology Ottawa Vein Centre I do not have relevant financial
More informationAdditional Information S-55
Additional Information S-55 Network providers are encouraged, but not required to participate in the on-line American Venous Forum Registry (AVR) - The First National Registry for the Treatment of Varicose
More informationPractical Point in Diabetic Foot Care 3-4 July 2017
Diabetic Foot Ulcer : Role of Vascular Surgeon Practical Point in Diabetic Foot Care 3-4 July 2017 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai University
More informationMultidisciplinary approach to BTK Y. Gouëffic, MD, PhD
Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD Department of vascular surgery, University Hospital of Nantes, France Response to the increased demand of hospital care Population is aging Diabetes
More informationRecommendations for Follow-up After Vascular Surgery Arterial Procedures SVS Practice Guidelines
Recommendations for Follow-up After Vascular Surgery Arterial Procedures 2018 SVS Practice Guidelines vsweb.org/svsguidelines About the guidelines Published in the July 2018 issue of Journal of Vascular
More informationLIMB SALVAGE IN THE DIABETIC PATIENT
LIMB SALVAGE IN THE DIABETIC PATIENT WHO? HOW? BEST? DISCLOSURES Educational grant from Cook Inc OBJECTIVES Review risk stratification and staging schemes for the threatened limb Discuss current concepts
More informationStratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI?
Stratifying Management Options for Patients with Critical Limb Ischemia: When Should Open Surgery Be the Initial Option for CLI? Peter F. Lawrence, M.D. Gonda Vascular Center Division of Vascular Surgery
More informationThe role of physical training in lowering the cardio-metabolic risk
The role of physical training in lowering the cardio-metabolic risk Timea Szasz 1, Eugen Bota 2, Lucian Hoble 3 Abstract The cardio-metabolic risk represents the overall risk of developing type 2 diabetes
More informationDisclosures. Talking Points. An initial strategy of open bypass is better for some CLI patients, and we can define who they are
An initial strategy of open bypass is better for some CLI patients, and we can define who they are Fadi Saab, MD, FASE, FACC, FSCAI Metro Heart & Vascular Metro Health Hospital, Wyoming, MI Assistant Clinical
More informationPAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014
PAD and CRITICAL LIMB ISCHEMIA: EVALUATION AND TREATMENT 2014 Van Crisco, MD, FACC, FSCAI First Coast Heart and Vascular Center, PLLC Jacksonville, FL 678-313-6695 Conflict of Interest Bayer Healthcare
More informationCase Discussion. Disclosures. Critical Limb Ischemia: A Selective Approach to Revascularization Works Best 4/28/2012. None. 58 yo M, DM, CAD, HTN
Critical Limb Ischemia: A Selective Approach to Revascularization Works Best None Disclosures Michael S. Conte MD, FACS Division of Vascular and Endovascular Surgery Co-Director, Heart and Vascular Center
More informationPractical Point in Holistic Diabetic Foot Care 3 March 2016
Diabetic Foot Ulcer : Vascular Management Practical Point in Holistic Diabetic Foot Care 3 March 2016 Supapong Arworn, MD Division of Vascular and Endovascular Surgery Department of Surgery, Chiang Mai
More informationPeripheral Vascular Disease
Peripheral artery disease (PAD) results from the buildup of plaque (atherosclerosis) in the arteries of the legs. For people with PAD, symptoms may be mild, requiring no treatment except modification of
More informationCurrent Vascular and Endovascular Management in Diabetic Vasculopathy
Current Vascular and Endovascular Management in Diabetic Vasculopathy Yang-Jin Park Associate professor Vascular Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine Peripheral artery
More informationLimb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017
Limb Salvage in Diabetic Ischemic Foot Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017 Case Male 67 years old Underlying DM, HTN, TVD Present with gangrene
More informationSTUDY ON THE CHRONIC ANTITHROMBOTIC TREATMENT AFTER SURGICAL REVASCULARIZATIONS IN THE PERIPHERAL ARTERIAL DISEASE
492 STUDY ON THE CHRONIC ANTITHROMBOTIC TREATMENT AFTER SURGICAL REVASCULARIZATIONS IN THE PERIPHERAL ARTERIAL DISEASE MARIAN BROASCĂ 1*, DANA ELENA NEDELCU 2 1 Floreasca Emergency Hospital, Calea Floreasca
More informationIntroduction. Risk factors of PVD 5/8/2017
PATHOPHYSIOLOGY AND CLINICAL FEATURES OF PERIPHERAL VASCULAR DISEASE Dr. Muhamad Zabidi Ahmad Radiologist and Section Chief, Radiology, Oncology and Nuclear Medicine Section, Advanced Medical and Dental
More informationDiagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC
Diagnosis and Endovascular Treatment of Critical Limb Ischemia: What You Need to Know S. Jay Mathews, MD, MS, FACC Interventional Cardiologist/Endovascular Specialist Bradenton Cardiology Center Bradenton,
More informationPHYSICAL EXERCISES FOR DIABETIC POLYNEUROPATHY
STUDIA UBB EDUCATIO ARTIS GYMN., LIX, 4, 2014, pp. 101-106 (RECOMMENDED CITATION) PHYSICAL EXERCISES FOR DIABETIC POLYNEUROPATHY DOCU AXELERAD ANY 1*, DOCU AXELERAD DANIEL 2 ABSTRACT. Introduction: Chronic
More informationBath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press)
Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN 0140-6736 (In Press) Access from the University of Nottingham repository: http://eprints.nottingham.ac.uk/1087/1/lancet_clots_1_20090522_4.pdf
More informationChronic Venous Insufficiency
Chronic Venous Insufficiency None Disclosures Lesley Enfinger, MSN,NP-C Chronic Venous Insufficiency Over 24 Million Americans affected by Chronic Venous Insufficiency (CVI) 10 x More Americans suffer
More informationInfection/ischaemia/amputation: how to build a multidisciplinary center for limb salvage
Infection/ischaemia/amputation: how to build a multidisciplinary center for limb salvage Roberto Ferraresi Peripheral Interventional Unit Bergamo Italy ferraresi.md@gmail.com Disclosure Roberto Ferraresi,
More informationThrombin injection vs Conventional Surgical Repair in Treatment of Iatrogenic Post-cath Femoral Artery Pseudoaneurysm (IFAP)
Kasr El Aini Journal of Surgery VOL., 11, NO 3 September 2010 31 Thrombin injection vs Conventional Surgical Repair in Treatment of Iatrogenic Post-cath Femoral Artery Pseudoaneurysm (IFAP) Farghaly A,
More informationUse of images in a surgery consultation. Will it improve the communication?
Chirurgia (2012) 107: 213-217 Nr. 2, Martie - Aprilie Copyright Celsius Use of images in a surgery consultation. Will it improve the communication? R. Vilallonga 1, J.M. Fort 1, N. Iordache 2, M. Armengol
More informationManaging Conditions Resulting from Untreated Cardiometabolic Syndrome
Managing Conditions Resulting from Untreated Cardiometabolic Syndrome Matthew P. Namanny DO, FACOS Vascular/Endovascular Surgery Saguaro Surgical/AZ Vascular Specialist Tucson Medical Center Critical Limb
More informationResident Teaching Conference 3/12/2010
Resident Teaching Conference 3/12/2010 Goals Definition and Classification of Acute Limb Ischemia Clinical Assessment of the Vascular Patient History and Physical Diagnostic Modalities Management of Acute
More informationHybrid Procedures for Peripheral Obstructive Disease - Step by Step -
Hybrid Procedures for Peripheral Obstructive Disease - Step by Step - Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name:..holger Staab... I have
More informationOHTAC Recommendation. Endovascular Laser Treatment for Varicose Veins. Presented to the Ontario Health Technology Advisory Committee in November 2009
OHTAC Recommendation Endovascular Laser Treatment for Varicose Veins Presented to the Ontario Health Technology Advisory Committee in November 2009 April 2010 Issue Background The Ontario Health Technology
More information4/23/2009. Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes. Lower Extremity Revascularization Options: Key Factors to Consider
Vein Bypass Remains the Gold Standard AND We Can Improve Outcomes Lower Extremity Revascularization Options: Key Factors to Consider General health of the patient Michael S. Conte MD Division of Vascular
More informationVENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?
VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK? Ayman El-Menyar (1), MD, Hassan Al-Thani (2),MD (1)Clinical Research Consultant, (2) Head of Vascular Surgery, Hamad General Hospital
More informationCase 37 Clinical Presentation
Case 37 73 Clinical Presentation The patient is a 62-year-old woman with gastrointestinal (GI) bleeding. 74 RadCases Interventional Radiology Imaging Findings () Image from a selective digital subtraction
More informationStep by step Hybrid procedures in peripheral obstructive disease. Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery
Step by step Hybrid procedures in peripheral obstructive disease Holger Staab, MD University Hospital Leipzig, Germany Clinic for Vascular Surgery Disclosure Speaker name: H.H. Staab I have the following
More informationRole of ABI in Detecting and Quantifying Peripheral Arterial Disease
Role of ABI in Detecting and Quantifying Peripheral Arterial Disease Difference in AAA size between US and Surgeon 2 1 0-1 -2-3 0 1 2 3 4 5 6 7 Mean AAA size between US and Surgeon Kathleen G. Raman MD,
More informationIntervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI
Intervention for Lower Extremity PAD: When, why and what?! Robert F Cuff, MD FACS RVT RPVI 1 Disclosures I have no financial disclosures related to this talk Objectives 1. Discuss indications for intervention
More informationLearning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship
Learning Objectives for Rotations in Vascular Surgery Year 3 Basic Clerkship CLINICAL PROBLEMS IN VASCULAR SURGERY 1. ABDOMINAL AORTIC ANEURYSM A 70 year old man presents in the emergency department with
More informationWill it heal? How to assess the probability of wound healing
Will it heal? How to assess the probability of wound healing Richard F. Neville, M.D. Professor of Surgery Chief, Division of Vascular Surgery George Washington University Limb center case 69 yr old male
More informationSurgery is and Remains the Gold Standard for Limb-Threatening Ischemia
Surgery is and Remains the Gold Standard for Limb-Threatening Ischemia Albeir Mousa, MD., FACS.,MPH., MBA Professor of Vascular and Endovascular Surgery West Virginia University Disclosure None What you
More informationPREVALENCE OF FRAILTY SYNDROME AMONG TYPE 2 DIABETES MELLITUS ELDERLY PATIENTS
Rom. J. Gerontol. Geriatr., 2018, Vol. 7, No. 1, p. 25-31 PREVALENCE OF FRAILTY SYNDROME AMONG TYPE 2 DIABETES MELLITUS ELDERLY PATIENTS Raluca Nacu 1, Anna Marie Herghelegiu 1,2, Gabriel Ioan Prada 1,2
More informationBC Vascular Day. Contents. November 3, Abdominal Aortic Aneurysm 2 3. Peripheral Arterial Disease 4 6. Deep Venous Thrombosis 7 8
BC Vascular Day Contents Abdominal Aortic Aneurysm 2 3 November 3, 2018 Peripheral Arterial Disease 4 6 Deep Venous Thrombosis 7 8 Abdominal Aortic Aneurysm Conservative Management Risk factor modification
More informationPopliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS
Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS Asymptomatic mass - 38-40%will develop symptoms at a rate of 14%/yr Intermittent claudic ation (chronic ischemia) - 25%-40%
More informationDOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS
TOKUDA HOSPITAL SOFIA DOPPLER ULTRASOUND OF DEEP VENOUS THROMBOSIS MILENA STANEVA, MD, PhD Department of vascular surgery and angiology Venous thromboembolic disease continues to cause significant morbidity
More informationTom Eisele, Benedikt M. Muenz, and Grigorios Korosoglou. Department of Cardiology & Vascular Medicine, GRN Hospital Weinheim, Weinheim, Germany
Case Reports in Vascular Medicine Volume 2016, Article ID 7376457, 4 pages http://dx.doi.org/10.1155/2016/7376457 Case Report Successful Endovascular Repair of an Iatrogenic Perforation of the Superficial
More informationPeripheral Arterial Disease. Westley Smith MD Vascular Fellow
Peripheral Arterial Disease Westley Smith MD Vascular Fellow Background (per 10,000) Goodney P, et al. Regional intensity of vascular care and lower extremity amputation rates. JVS. 2013; 6: 1471-1480.
More informationDisclosures. What is a Specialty Vein Clinic? Prevalence of Venous Disease. Management of Venous Disease: an evidence based approach.
Management of Venous Disease: an evidence based approach Disclosures Ed Boyle, MD Andrew Jones, MD Dr. Ed Boyle and Dr. Andrew Jones disclose Grants/research support: Medtronic, BTG International, Clearflow,
More informationEndovascular Should Be Considered First Line Therapy
Revascularization of Patients with Critical Limb Ischemia Endovascular Should Be Considered First Line Therapy Michael Conte David Dawson David L. Dawson, MD Revised Presentation Title A Selective Approach
More informationTREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY
TREATMENT OPTIONS FOR CHRONIC VENOUS INSUFFICIENCY TL LUK Consultant Vascular Surgeon Sarawak General Hospital HKL Vascular Conference 19/06/2013 PREVALENCE OF LOWER LIMB VENOUS DISEASE Affects half of
More informationDisclosures. Critical Limb Ischemia. Vascular Testing in the CLI Patient. Vascular Testing in Critical Limb Ischemia UCSF Vascular Symposium
Disclosures Vascular Testing in the CLI Patient None 2015 UCSF Vascular Symposium Warren Gasper, MD Assistant Professor of Surgery UCSF Division of Vascular Surgery Critical Limb Ischemia Chronic Limb
More informationBC Vascular Surgery Day
BC Vascular Surgery Day November 4, 2017 1 Table of Contents Abdominal Aortic Aneurysm 3 4 Acute DVT 5 6 Peripheral Arterial Disease 7 9 Varicose Veins 10 11 Diabetic Foot Ulcers 12 13 Carotid Stenosis
More informationVascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2)
Vascular Surgery Rotation Objectives for Junior Residents (PGY-1 and 2) Definition Vascular surgery is the specialty concerned with the diagnosis and management of congenital and acquired diseases of the
More informationHow to manage leg ulcers in the elderly
How to manage leg ulcers in the elderly David Riding Clinical Research Fellow / Specialty Registrar in Vascular Surgery University of Manchester / MFT British Geriatric Society Trainees Meeting 2018 Objectives
More informationAccess strategy for chronic total occlusions (CTOs) is crucial
Learn How Access Strategy Impacts Complex CTO Crossing Arthur C. Lee, MD The Cardiac & Vascular Institute, Gainesville, Florida VASCULAR DISEASE MANAGEMENT 2018;15(3):E19-E23. Key words: chronic total
More informationVasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy and Dental Medicine, Arad, Romania
ENDOVASCULAR TREATMENT FOR VASCULAR GRAFT RESTENOSIS Bogdan Totolici 1, Francisca Blanca Călinescu 1*, Ionel Droc 2, Carmen Neamţu 1 1 Vasile Goldiş Western University of Arad Faculty of Medicine, Pharmacy
More informationPhysician s Vascular Interpretation Examination Content Outline
Physician s Vascular Interpretation Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 6 Cerebrovascular Abdominal Peripheral Arterial - Duplex Imaging Peripheral Arterial
More informationDetermine the patients relative risk of thrombosis. Be confident that you have had a meaningful discussion with the patient.
Patient Assessment :Venous History, Examination and Introduction to Doppler and PPG Dr Louis Loizou The 11 th Annual Scientific Meeting and Workshops of the Australasian College of Phlebology Tuesday 18
More informationTHE RESULTS OF THE SURGICAL TREATMENT OF SUPERFICIAL VENOUS THROMBOSIS
Journal of Experimental Medical & Surgical Research Cercetãri Experimentale & Medico-Chirurgicale Year XVII Nr.2/2010 Pag. 81-86 JOURNAL Experimental Medical of Surgical R E S E A R C H THE RESULTS OF
More informationSANGER HEART & VASCULAR INSTITUTE
VASCULAR SURGERY & MEDICINE PROGRAM GUIDE SANGER HEART & VASCULAR INSTITUTE Vascular Surgery & Medicine Program Guide About Us...1 Vascular Surgery & Medicine...3 Comprehensive Aortic Disease Management...5
More informationRECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY
RECOGNITION AND ENDOVASCULAR TREATMENT OF CHRONIC VENOUS INSUFFICIENCY Paul Kramer, MD, FACC, FSCAI Liberty Cardiovascular Specialists Liberty Regional Heart and Vascular Center DISCLOSURES NONE Venous
More informationNational Vascular Registry
National Vascular Registry Bypass Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or postcode.
More informationSc. Parasit., 2009, 1-2, 26-31
Immunochromatography versus microscopy for the identification of Giardia lamblia and cryptosporidium parvum in human feces Imunocromatografie versus microscopie în identificarea Giardia lamblia si Cryptosporidium
More informationSubjects with Elevated CRP Levels and Asymptomatic PAD Prone to Develop Cognitive Impairment
Subjects with Elevated CRP Levels and Asymptomatic PAD Prone to Develop Cognitive Impairment Pavel Dan Nanu 1, Sanda Maria Deme 1, Ramona Maria Chendereş 1 Abstract: The CRP is an independent predictor
More informationIs there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data)
Is there still any space left for DES in the BTK area??? (Angiolite BTK trial, 6 month Data) (Angiolite BTK DES, IVascular) P. Goverde MD, K. Taeymans MD, K. Lauwers MD Vascular Clinic ZNA Antwerp,Belgium
More informationThere are multiple endovascular options for treatment
Peripheral Rotablator Atherectomy: The Below-the-Knee Approach to Address Calcium Head On Peripheral Rotablator s front-cutting, diamond-tipped burr provides stable rotation in calcified lesions. BY SONYA
More informationNCVH. Ultrasongraphy: State of the Art Vein Forum 2015 A Multidisciplinary Approach to Otptimizing Venous Circulation From Wounds to WOW
Ultrasongraphy: State of the Art 2015 NCVH New Cardiovascular Horizons Vein Forum 2015 A Multidisciplinary Approach to Otptimizing Venous Circulation From Wounds to WOW Anil K. Chagarlamudi, M.D. Cardiovascular
More information9/7/2018. Disclosures. CV and Limb Events in PAD. Challenges to Revascularization. Challenges. Answering the Challenge
Disclosures State-of-the-Art Endovascular Lower Extremity Revascularization Promotional Speaker Jansen Pharmaceutical Promotional Speaker Amgen Pharmaceutical C. Michael Brown, MD, FACC al Cardiology Associate
More informationPeripheral Arterial Disease: A Practical Approach
Peripheral Arterial Disease: A Practical Approach Sanjoy Kundu BSc, MD, FRCPC, DABR, FASA, FCIRSE, FSIR The Scarborough Hospital Toronto Endovascular Centre The Vein Institute of Toronto Scarborough Vascular
More informationPREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational
More informationRecent Advances in Peripheral Salvage
Recent Advances in Peripheral Salvage Dr Shaiful Azmi Yahaya, MD, MMed, FNHAM, FAsCC, FAPSIC Consultant Cardiologist and Peripheral Interventionist, Institut Jantung Negara Disclosure I am proctoring for
More informationCURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow
CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired
More informationIMAGING ASPECTS OF COMMUNICATING VEINS IN CHRONIC VENOUS INSUFFICIENCY
IMAGING ASPECTS OF COMMUNICATING VEINS IN CHRONIC VENOUS INSUFFICIENCY C. R. ŞOFARIU 1, D. SABĂU 2 1 Children s Hospital Sibiu, 2 Lucian Blaga University of Sibiu Keywords: chronic venous insufficiency,
More informationDisclosures. Tips and Tricks for Tibial Intervention. Tibial intervention overview
Tips and Tricks for Tibial Intervention Donald L. Jacobs, MD C Rollins Hanlon Endowed Professor and Chair Chair of Surgery Saint Louis University SSM-STL Saint Louis University Hospital Disclosures Abbott
More informationEndovascular Intervention BtK Intervention in Patients with Chronic Dialysis
Endovascular Intervention BtK Intervention in Patients with Chronic Dialysis GB Danzi, MD Ospedale Maggiore Policlinico Milan Italy Disease Pattern in PAD Hypercholesterolemia Age ESRD Current smoking
More informationLIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37:
LIBERTY 360 Study LIBERTY is a prospective, observational, multi-center study to evaluate procedural and long-term clinical and economic outcomes of endovascular device interventions in patients with symptomatic
More informationTraumatic Posterior Tibial Pseudoaneursym: A rare late complication repaired conventionally
Volume 2 Issue 3 Article 3 2016 Traumatic Posterior Tibial Pseudoaneursym: A rare late complication repaired conventionally Farzad Amiri, MD; Zachary Sanford; and Constantinous Constantinou, MD Follow
More informationTreatment Strategies For Patients with Peripheral Artery Disease
Treatment Strategies For Patients with Peripheral Artery Disease Presented by Schuyler Jones, MD Duke University Medical Center & Duke Clinical Research Institute AHRQ Comparative Effectiveness Review
More informationNational Vascular Registry
National Vascular Registry Angioplasty Patient Details Patient Consent* 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s) or
More informationPopliteal Artery Aneurysms: Diagnosis and Repair Options
Deepak N. Deshmukh DO April 27, 2018 Popliteal Artery Aneurysms: Diagnosis and Repair Options No Disclosures Popliteal Artery Aneurysms (PAAs) Male Predominanace Most common peripheral Aneurysm (70%) 30-50%
More informationAcute arterial embolism
Acute arterial embolism Definition Thrombus come from heart or blood vessel or other embolus such as tumor,air gas or fat flow with blood stream and occlude distal limb or visceral arteries which causes
More informationAngiosome concept myth or truth? Does it make a real difference in real world cases?
Angiosome concept myth or truth? Does it make a real difference in real world cases? Osamu Iida, MD, FACC Kansai Rosai Hospital Amagasaki, Hyogo, Japan Disclosure Speaker name:... I have the following
More informationHandbook for Venous Thromboembolism
Handbook for Venous Thromboembolism Gregory Piazza Benjamin Hohlfelder Samuel Z. Goldhaber Handbook for Venous Thromboembolism Gregory Piazza Cardiovascular Division Harvard Medical School Brigham and
More informationDisclosures. In-Stent Restenosis: The Tail IS Wagging the Dog 4/15/2016. Restenosis: The Continuing Challenge for Peripheral Vascular Intervention
In-Stent Restenosis: The Tail IS Wagging the Dog Disclosures NONE Michael S. Conte MD Division of Vascular and Endovascular Surgery UCSF Heart and Vascular Center UCSF Vascular Symposium 2016 IF YOU WERE
More informationAggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts
Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts Dr Steven Kum MBBS MMed FRCS FAMS Vascular & Endovascular Surgeon Vascular Centre Department of Surgery Changi
More informationPerfusion Assessment in Chronic Wounds
Perfusion Assessment in Chronic Wounds American Society of Podiatric Surgeons Surgical Conference September 22, 2018 Michael Maier, DPM, FACCWS Cardiovascular Medicine Cleveland Clinic Disclosures Speaker,
More informationPeripheral arterial disease for primary care Ed Aboian, MD
Peripheral arterial disease for primary care Ed Aboian, MD Division of Vascular and Endovascular Surgery Palo Alto Medical Foundation, Burlingame Ca Disclosures Nothing to disclose Clinical presentation
More informationArterial Studies And The Diabetic Foot Patient
Arterial Studies And The Patient George L. Berdejo, BA, RVT, FSVU gberdejo@wphospital.org Disclosures I have nothing to disclose! Diabetes mellitus continues to grow in global prevalence and to consume
More informationCo-Conveners: Nadia Wise (Adelaide) and Conor Marron (Adelaide) VASCULAR SOCIETY OF INDIA AND RARE VASCULAR DISORDERS (Combined with: Nursing)
VASCULAR Co-Conveners: Nadia Wise (Adelaide) and Conor Marron (Adelaide) SATURDAY 17 AUGUST 8:30am - 10:00am VASCULAR SOCIETY OF INDIA AND RARE VASCULAR DISORDERS (Combined with: Nursing) Carotid body
More informationTreatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue)
Treatment of Venous ulcers utilizing n-butyl Cyanoacrylate (Super Glue) Awais Siddique MD Endovascular Radiologist AZH WAVE CENTERS Milwaukee WI Venous disease Etiology Are the result of Venous valvular
More information